Background Venous leg ulcers (VLUs) are typically painful and heal slowly. Compression therapy offers high healing rates; however, improvements are not usually sustained. Exercise is a low-cost, low-risk and effective strategy for improving physical and mental health. Little is known about the feasibility and efficacy of supervised exercise training used in combination with compression therapy patients with VLUs. Objectives To assess the feasibility of a 12-week supervised exercise programme as an adjunct therapy to compression in patients with VLUs. Methods This was a two-centre, two-arm, parallel-group, randomized feasibility trial. Thirty-nine patients with venous ulcers were recruited and randomized 1 : 1 either to exercise (three sessions weekly) plus compression therapy or compression only. Progress/success criteria included exercise attendance rate, loss to follow-up and patient preference. Baseline assessments were repeated at 12 weeks, 6 months and 1 year, with healing rate and time, ulcer recurrence and infection incidents documented. Intervention and healthcare utilization costs were calculated. Qualitative data were collected to assess participants' experiences. Results Seventy-two per cent of the exercise group participants attended all scheduled exercise sessions. No serious adverse events and only two exercise-related adverse events (both increased ulcer discharge) were reported. Loss to follow-up was 5%. At 12 months, median ulcer healing time was lower in the exercise group (13 vs. 34Á7 weeks). Mean National Health Service costs were £813Á27 for the exercise and £2298Á57 for the control group. Conclusions The feasibility and acceptability of both the supervised exercise programme in conjunction with compression therapy and the study procedures is supported.
What does this study add?
• The findings support the feasibility and acceptability of supervised exercise training as an adjunct therapy for adults with VLUs.
• The preliminary data also support the potential effectiveness of exercise training in improving ulcer healing.
• An appropriately powered, multicentre trial is required to confirm the clinical and cost-effectiveness of the intervention.
Almost 70% of all leg ulcers have a venous component. 1 Occurrence of venous leg ulcers (VLUs) increases with age, with the U.K. prevalence in those > 65 years of age being estimated at about 3%. 2 VLUs arise from venous valve incompetence and calf muscle pump insufficiency, which leads to venous stasis and hypertension. This results in microcirculatory changes and localized tissue ischaemia. 3, 4 The natural history of VLUs is of a continuous cycle of healing and breakdown over decades: 5 VLUs are typically painful and heal slowly, resulting in an impaired quality of life (QoL), social isolation and reduced work productivity. 6 Treatment of this major health problem results in a considerable cost to the National Health Service (NHS): each ulcer costs up to £1981 per year; 7 estimated total healthcare costs are between £198 million and £400 million per year, 8, 9 with 65% of these costs occurring in the community. 10 Lower-limb compression therapy is an established first-line therapy for VLUs, 11 with approximately 50% of VLUs closing within 24 weeks. 10 Nevertheless, recurrence rates remain high (up to 56% within 4 years). 12 Furthermore, up to 30% of VLUs do not respond to compression alone, remain open after 1 year of treatment and need an average of 51 treatment visits to heal. 10, 11, 13 Therefore, it is important to develop adjunct therapies to compression, which would improve healing outcomes. Lifestyle factors, including nutrition, exercise and smoking, are mentioned in guidelines on the management of VLUs but receive relatively little emphasis.
14 Exercise training might enhance ulcer healing and other aspects of health, and is routinely prescribed for other cardiovascular diseases (e.g. peripheral arterial disease and coronary artery disease). 15, 16 In patients with VLUs, supervised calf muscle exercise has been shown to increase calf muscle pump function and improve lower-limb haemodynamics, 17, 18 as well as mobility and QoL. [19] [20] [21] A recent systematic review suggested further research to determine whether exercise training has an effect on ulcer healing and QoL. 22 Our team recently completed 'FISCU' [Feasibility of Implementing Supervised exercise training alongside Compression therapy in people with venous Ulceration; a National Institute for Health Research-funded study (PB-PG-0213-30029)] 5 to assess the feasibility of a 12-week supervised exercise programme combining aerobic, resistance and flexibility exercises as an adjunct therapy to compression in patients with VLUs. We report on rates of screening, eligibility, recruitment, retention, outcome completion, exercise adherence and adverse events (AEs). We also report on reasons for exclusion and nonconsent, sample characteristics, the distribution and completeness of potential primary outcomes, and provide information on preliminary data on effectiveness and healthcare resource use.
Patients and methods
A full description of methods is available in our previously published protocol paper. 5 The study was a two-arm, parallelgroup, randomized controlled feasibility trial conducted in two U.K. sites (Lincoln and Sheffield). Ethics approval was granted by the NHS National Research Ethics Service, Yorkshire and the Humber (Sheffield) Committee (14/YH/0091), and all participants provided written informed consent prior to enrolment. The trial was prospectively registered (Current Controlled Trials ISRCTN10205425).
Participants
Participants were recruited from community nursing and tissue viability teams or services, community and outpatient leg ulcer clinics, and newspaper advertisement. Inclusion and exclusion criteria are given in Table 1 .
Randomization, allocation concealment and blinding
Following baseline assessments, participants were randomly assigned 1 : 1 to an intervention group or a control group. Participants were stratified by ulcer size (maximum ulcer diameter 1-3 cm or > 3 cm in any direction). Outcome assessors were blinded to group allocation.
Interventions
All participants received standard compression therapy directed by experienced tissue-viability nurses, following standard local practice. Patients were reviewed in clinics as considered clinically necessary, with no interference by the study team. Participants randomized to the exercise group were invited to attend three sessions of supervised exercise each week for 12 weeks (total of 36 sessions) at one of the two study exercise training facilities (Sheffield Hallam University and University of Lincoln). For details on the exercise components see Table S1 (Supporting Information).
Study schedule and assessments
During visit 1, after written informed consent had been obtained and eligibility confirmed (which included a medical examination), the following baseline measurements were recorded at one of the two research centres (Sheffield Hallam University, University of Lincoln): (i) demographic data, including age, sex and socioeconomic status; (ii) clinical history, current medications, stature, body mass, ankle and calf circumference; (iii) ulcer size; (iv) ankle brachial pressure index (ABPI; a Doppler-determined measurement of ABPI was performed according to the procedures of Aboyans et al., 23 unless a reading < 3 months old could be obtained from clinical records, following the patient's consent); (v) baseline exercise history; (vi) health-related QoL (HRQoL) questionnaires (EQ-5D-5L and VEINES-QOL); [24] [25] [26] 28 and ankle range of motion assessed using a bi-plane ankle goniometer. All participants were given a resource use diary to complete at home for the duration of the study (to conduct health economics analysis).
Participants were then randomized to one of the two groups, as described above.
At 12 weeks and 12 months, participants had the following measures and tests repeated: physical fitness, microvascular function, ulcer-related clinical data (size, status and recurrence) and medications, body mass and HRQoL questionnaires. A copy of the resource use diary was also taken. A postal assessment involving the completion of HRQoL questionnaires was also undertaken at 6 months.
Feasibility and acceptability outcomes
Recruitment rates were measured as rate of invited participants who were eligible and consenting. Acceptability of allocation was assessed by examining reasons for dropout in discontinuing participants and comparing attrition rates between the two study groups. Suitability of measurement procedures was evaluated by outcome completion rates and reasons for missing data. Attrition rate was established as discontinuation of intervention and loss to follow-up measurement for all conditions. The acceptability of the exercise programmes was assessed by using session attendance and compliance data and participant feedback via one-to-one semi-structured interviews conducted with a subgroup of participants after the 3-month follow-up visit (detailed analysis will be presented elsewhere). The safety of exercise training was also assessed by exploring reasons for dropout from the exercise programme and the number and type of AEs that occurred in each group.
Sample size
Sample size calculation was based on willingness for randomization and aimed to recruit 80 participants within an 18-month recruitment period (Table S1 ; see Supporting Information).
Data analysis
All analyses were conducted on an intention-to-treat basis, conducted in SPSS version 24 (IBM, Armonk, NY, U.S.A.). Missing data were reported by trial arm with description of underlying reasons.
Baseline
Summary tables report all baseline variables, and clinical, fitness and patient-reported outcome variables. Continuous variables were summarized with descriptive statistics. Frequency counts and percentages were provided for categorical data.
Feasibility and acceptability
For success criteria, see Table 2 . Outcomes used to assess the feasibility and acceptability of key trial parameters were rates of eligibility, recruitment, retention, outcome completion, exercise adherence and AEs. 5 Group preference, reasons for exclusion and nonconsent, sample characteristics and the distribution of potential primary outcomes are presented.
Clinical, fitness and patient-reported outcomes
Descriptive statistics are presented for clinical, fitness and patient-reported outcomes at each time point.
Economic evaluation
A prospective economic evaluation was rehearsed to develop and refine the methods for a subsequent definitive trial (Appendix S1; see Supporting Information). 
Results

Screening, eligibility and recruitment
A summary of feasibility and acceptability data is presented in Table 3 . All success criteria were met (e.g. 72% of participants completed all exercise sessions, loss to follow-up was 5%, patient preference to the exercise group was 44%, whereas median ulcer healing time was chosen as the primary outcome for the definitive trial). Of 514 patients screened for participation, 109 met the eligibility criteria and 39 (24 men, 15 women) were recruited, giving eligibility and recruitment rates of 21% and 36%, respectively. Sites 1 and 2 recruited 38 and one participants, respectively. Reasons for nonconsent and exclusion are shown in Figure 1 .
Group allocation, group preference and participant characteristics
Eighteen participants were allocated to exercise and 21 to usual care. Seventeen (63%) of 27 participants expressed a preference for exercise (12 expressed no preference). Participant characteristics at baseline are shown in Table 4 ; the groups were well balanced for most variables except QoL.
Retention
Retention rate was 95%. Two of 39 participants formally left the study; one from the exercise group for ulcer pain before the 3-month assessment and one from the control group for nonulcer-related health reasons before the 6-month assessment. All others completed all assessment sessions. Four participants withdrew from exercise training due to family commitments and nonulcer-related health reasons.
Exercise attendance and safety data
Of the 18 exercise participants, 13 (72%) completed all sessions; overall session completion rate was 79% (n = 512/ 648). No bandage slippage/misplacement was detected during exercise sessions. We observed two exercise-related AEs (both excessive discharge from the ulcer). Actions taken included the removal of resistance exercises and postponement of exercise sessions.
Physical function and body mass
Participants in the exercise group showed higher mean values at 3 months in all tests (Table 5) . Results stabilized at 12 months for all tests except plantar flexion. Weight reduction was modest for the exercise group in relation to the baseline (mean AE SD 103Á9 AE 24 kg at baseline vs. 99Á8 AE 28Á4 kg at 12 months). In contrast there was an increase in weight in the control group (mean AE SD 102Á6 AE 25Á6 kg vs. 105Á7 AE 25Á2 kg at 12 months).
Ulcer-related data
Median ulcer size was similar between groups at 12 months (Table 6 ), but healing rate was higher in the intervention group (83% vs. 60%), with shorter median (range) ulcer healing time [13 (3Á9-52) vs. 34Á7 (4Á3-52) weeks]. Recurrence rates were low in both groups (two in the intervention group, one in the control group).
Health-related quality of life
Participants in the intervention group started the study with a higher EQ-5D utility score than the control group (Table 7; mean AE SD 0Á8022 AE 0Á17 vs. 0Á6010 AE 0Á35). This difference was maintained throughout the study. A similar difference was observed with EQ visual analogue scale, VEINES-QOL (overall score and symptom score) and pain score, although for VEINES-QOL and pain score, the difference between groups was increased from 3 months onwards.
Health economic data
There were no missing data for procedure costs. Mean exercise intervention costs per participant was £610Á22, including staff time, room hire and patient reimbursement. Mean total NHS Table 2 Criteria for success/progression An appropriate primary outcome variable is defined At least 67% of randomly assigned patients in the exercise group are compliant with the intervention (defined as at least 75% of the scheduled sessions completed as planned) Loss to follow-up at 12 months is < 20% Patient preferences are not so strong that they result in the conclusion that a randomized controlled trial is not a feasible design 
Follow-up
Lost to follow-up (n = 1, unwillingness to continue the study due to non-ulcer-related health problems at after 3 months of follow-up)
Lost to follow-up (n = 1, unwillingness to continue the study due to to ulcer pain before 3-month follow-up) Discontinued exercise but remained in the study (n = 4, one due to ulcer-related problems, three due to nonulcer-related health problems). costs (based on NHS National Tariff Schedules and calculated based on visits and usage of NHS resources) were calculated as £813Á27 for the exercise and £2298Á57 for the control group.
Personal costs were calculated using a diary with 'out-ofpocket' expenses being estimated at £113Á63 and £174Á58 for the exercise and control groups, respectively.
The mean 'per patient' cost savings to the NHS from the exercise intervention was £875Á08. Similarly, the 'per patient' less 'out-of-pocket' expenses to participants, as a result of participation in exercise intervention, was £60Á95. The combined per 'per patient' mean total cost saving was £936Á03 (Table 8 and Appendix S1; see Supporting Information).
Discussion
We successfully assessed several feasibility study aspects, including recruitment, baseline and follow-up measurements, Data are n (%) unless otherwise indicated. SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; bpm, beats per min; ABPI, ankle brachial pressure index. (5) NA, not available. as well as the feasibility and preliminary effectiveness of a supervised exercise programme for people with VLUs. Our main finding was that the study procedures were feasible and acceptable.
The feasibility and acceptability of using a supervised exercise regime as an adjunct therapy to compression therapy had been an area of uncertainty prior to this study. Indeed, during the preliminary study stages, such a notion was met with scepticism by some clinicians and patients, who believed that exercise may be either inappropriate or harmful, and may delay rather than promote healing -an attitude that has also been documented in the literature. 29, 30 Nevertheless, the majority of the eligible patients had a positive attitude towards undertaking exercise in addition to following a therapeutic pathway based on compression therapy. This was irrespective of whether they consented to take part and reasons for nonparticipation will help make the programme more accessible (i.e. by choosing appropriate venues). Our feasibility data show few AEs, with no bandage misplacement or slippage incidents, one of the biggest concerns of collaborating clinicians. Exercise attendance was 79%, with 72% of participants completing all sessions. This is high considering that many participants were old, frail and had no previous exercise experience. This was achieved without employing any specific adherence-enhancing components or provision of behavioural change support, which could have potentially improved attendance rates and the effect of the intervention even further. 31 This suggests great interest and self-motivation from our participants, which will be a decisive factor for the success of a definitive trial and any wider roll-out of the intervention. However, despite our success, it is our plan to incorporate cognitive-behavioural strategies as part of any future trial to optimize exercise adherence and increase any potential, positive effect.
With regard to practicality our intervention was primarily delivered within a university setting, at some distance from the clinics in which our participants were treated. The high attendance rate suggests that this did not have a negative impact on the outcome, although it may have affected recruitment rate. Recruitment rate may be improved in the definitive trial, where 12-week exercise referral schemes will be utilized for the intervention delivery. 32 Delivery with an option of times in community-based venues increases accessibility but comes with a number of challenges (as adherence and success varies); 33 recent research suggests that these schemes can offer QoL and physical activity gains. 34 Our findings support the feasibility of using diaries to collect economic data on patients' usage of NHS resources, healthcare visits, prescriptions and out-of-pocket expenses. The findings suggest potential savings to both the NHS (£875Á08 per patient) and patients (£60Á95 reduction in out-of-pocket expenses). Nevertheless, as our analysis was purely descriptive, an appropriate health economics analysis in the definitive trial will provide greater certainty regarding cost-effectiveness.
Overall, no major difficulties were identified in the design or implementation of trial procedures. For example, the blinding procedures ran as intended, the rates of retention and outcome completion (including the 6-month postal assessment) was very good, and from a point onwards there was an excellent communication between clinical and research teams, which allowed smooth recruitment. There was an imbalance between groups in the EQ-5D-5L data; this did not affect the success of our study but may need to be considered in planning the definitive trial.
Designing, setting up and managing a definitive, multicentre study has other challenges besides recruitment rate, data collection and exercise delivery. One important issue is the recruitment of a sufficient number of sites which will: (i) deliver the required number of participants; (ii) have experienced clinicians to act as local Principal Investigators; (iii) have dedicated tissue viability services, which will support and promote the study; and (iv) have a good communication level between exercise deliverers, tissue viability clinics, local stakeholders (e.g. NHS Trusts) and the main research team. It is therefore advisable that a clinical trials unit is utilised to safeguard data quality and guarantee database management, in addition to costing dedicated personnel (e.g. a trial coordinator and a trial manager) for day-to-day study management and involving experienced research sites in previous, similar studies (which would safeguard a consistent delivery of the trial protocol). Our findings support the feasibility and acceptability of both the supervised exercise programme in conjunction with compression therapy and the study procedures and all our success criteria were met. 5 In addition, our results suggest that there may be significant potential benefit in healing rates and that, if this were confirmed in a full trial, the introduction of supervised exercise for VLU may well also save costs for the NHS. The next step will be the design and implementation of an appropriately powered, multicentre trial, which is required to provide answers to the questions of the clinical and cost-effectiveness of the intervention.
